117 related articles for article (PubMed ID: 26098110)
21. Systemic treatment with neuropeptide Y receptor Y1-antagonist enhances atherosclerosis and stimulates IL-12 expression in ApoE deficient mice.
Jääskeläinen AE; Seppälä S; Kakko T; Jaakkola U; Kallio J
Neuropeptides; 2013 Apr; 47(2):67-73. PubMed ID: 23261359
[TBL] [Abstract][Full Text] [Related]
22. Protective role of cytochrome P450 1A1 (CYP1A1) against benzo[a]pyrene-induced toxicity in mouse aorta.
Uno S; Sakurai K; Nebert DW; Makishima M
Toxicology; 2014 Feb; 316():34-42. PubMed ID: 24394547
[TBL] [Abstract][Full Text] [Related]
23. Endoglin as a possible marker of atorvastatin treatment benefit in atherosclerosis.
Rathouska J; Vecerova L; Strasky Z; Slanarova M; Brcakova E; Mullerova Z; Andrys C; Micuda S; Nachtigal P
Pharmacol Res; 2011 Jul; 64(1):53-9. PubMed ID: 21440631
[TBL] [Abstract][Full Text] [Related]
24. Curcumin modulation of high fat diet-induced atherosclerosis and steatohepatosis in LDL receptor deficient mice.
Hasan ST; Zingg JM; Kwan P; Noble T; Smith D; Meydani M
Atherosclerosis; 2014 Jan; 232(1):40-51. PubMed ID: 24401215
[TBL] [Abstract][Full Text] [Related]
25. Multiplex coherent anti-stokes Raman spectroscopy images intact atheromatous lesions and concomitantly identifies distinct chemical profiles of atherosclerotic lipids.
Kim SH; Lee ES; Lee JY; Lee ES; Lee BS; Park JE; Moon DW
Circ Res; 2010 Apr; 106(8):1332-41. PubMed ID: 20299664
[TBL] [Abstract][Full Text] [Related]
26. Aqueous extract of unripe Rubus coreanus fruit attenuates atherosclerosis by improving blood lipid profile and inhibiting NF-κB activation via phase II gene expression.
Kim S; Kim CK; Lee KS; Kim JH; Hwang H; Jeoung D; Choe J; Won MH; Lee H; Ha KS; Kwon YG; Kim YM
J Ethnopharmacol; 2013 Mar; 146(2):515-24. PubMed ID: 23353895
[TBL] [Abstract][Full Text] [Related]
27. [Peroxisome proliferator-activated receptor α/γ agonist tesaglitazar stabilizes atherosclerotic plaque in diabetic low density lipoprotein receptor knockout mice].
Zhang BC; Li XK; Che WL; Li WM; Hou L; Wei YD; Xu YW
Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Feb; 41(2):143-9. PubMed ID: 23710746
[TBL] [Abstract][Full Text] [Related]
28. Deficiency of inducible NO synthase reduces advanced but not early atherosclerosis in apolipoprotein E-deficient mice.
Miyoshi T; Li Y; Shih DM; Wang X; Laubach VE; Matsumoto AH; Helm GA; Lusis AJ; Shi W
Life Sci; 2006 Jul; 79(6):525-31. PubMed ID: 16516241
[TBL] [Abstract][Full Text] [Related]
29. Simvastatin suppresses apoptosis in vulnerable atherosclerotic plaques through regulating the expression of p(53), Bcl-2 and Bcl-xL.
Qin W; Lu Y; Zhan C; Shen T; Dou L; Man Y; Wang S; Xiao C; Bian Y; Li J
Cardiovasc Drugs Ther; 2012 Feb; 26(1):23-30. PubMed ID: 22038096
[TBL] [Abstract][Full Text] [Related]
30. EphA2 knockdown attenuates atherosclerotic lesion development in ApoE(-/-) mice.
Jiang H; Li X; Zhang X; Liu Y; Huang S; Wang X
Cardiovasc Pathol; 2014; 23(3):169-74. PubMed ID: 24561077
[TBL] [Abstract][Full Text] [Related]
31. [Impact of rosuvastatin on atherosclerosis lesions in apolipoprotein E knockout mice].
Luo RN; Tao LJ; Zhou J; Wang R; Lu MM; Fu X
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Aug; 39(8):743-8. PubMed ID: 22169423
[TBL] [Abstract][Full Text] [Related]
32. Adhesion of T and B lymphocytes to mouse atherosclerotic aortas: association with lesion topology and VCAM-1 expression.
Møller F; Andersen CB; Nielsen LB
Scand J Clin Lab Invest; 2005; 65(7):559-70. PubMed ID: 16271987
[TBL] [Abstract][Full Text] [Related]
33. Reduced atherosclerotic lesions in P2Y1/apolipoprotein E double-knockout mice: the contribution of non-hematopoietic-derived P2Y1 receptors.
Hechler B; Freund M; Ravanat C; Magnenat S; Cazenave JP; Gachet C
Circulation; 2008 Aug; 118(7):754-63. PubMed ID: 18663083
[TBL] [Abstract][Full Text] [Related]
34. Danhong injection inhibits the development of atherosclerosis in both Apoe⁻/⁻ and Ldlr⁻/⁻ mice.
Chen Y; Liu M; Zhao T; Zhao B; Jia L; Zhu Y; Zhang B; Gao X; Li G; Li X; Xiang R; Han J; Duan Y
J Cardiovasc Pharmacol; 2014 May; 63(5):441-52. PubMed ID: 24803317
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-1 receptor type-1 in non-hematopoietic cells is the target for the pro-atherogenic effects of interleukin-1 in apoE-deficient mice.
Shemesh S; Kamari Y; Shaish A; Olteanu S; Kandel-Kfir M; Almog T; Grosskopf I; Apte RN; Harats D
Atherosclerosis; 2012 Jun; 222(2):329-36. PubMed ID: 22236482
[TBL] [Abstract][Full Text] [Related]
36. Resveratrol protects against atherosclerosis, but does not add to the antiatherogenic effect of atorvastatin, in APOE*3-Leiden.CETP mice.
Berbée JF; Wong MC; Wang Y; van der Hoorn JW; Khedoe PP; van Klinken JB; Mol IM; Hiemstra PS; Tsikas D; Romijn JA; Havekes LM; Princen HM; Rensen PC
J Nutr Biochem; 2013 Aug; 24(8):1423-30. PubMed ID: 23337345
[TBL] [Abstract][Full Text] [Related]
37. Nicotinic acid has anti-atherogenic and anti-inflammatory properties on advanced atherosclerotic lesions independent of its lipid-modifying capabilities.
Holzhäuser E; Albrecht C; Zhou Q; Buttler A; Preusch MR; Blessing E; Katus HA; Bea F
J Cardiovasc Pharmacol; 2011 Apr; 57(4):447-54. PubMed ID: 21242806
[TBL] [Abstract][Full Text] [Related]
38. Angiotensin-(1-7) dose-dependently inhibits atherosclerotic lesion formation and enhances plaque stability by targeting vascular cells.
Yang JM; Dong M; Meng X; Zhao YX; Yang XY; Liu XL; Hao PP; Li JJ; Wang XP; Zhang K; Gao F; Zhao XQ; Zhang MX; Zhang Y; Zhang C
Arterioscler Thromb Vasc Biol; 2013 Aug; 33(8):1978-85. PubMed ID: 23723368
[TBL] [Abstract][Full Text] [Related]
39. Anti-atherosclerosis and hyperlipidemia effects of herbal mixture, Artemisia iwayomogi Kitamura and Curcuma longa Linne, in apolipoprotein E-deficient mice.
Shin HS; Han JM; Kim HG; Choi MK; Son CG; Yoo HR; Jo HK; Seol IC
J Ethnopharmacol; 2014 Apr; 153(1):142-50. PubMed ID: 24508858
[TBL] [Abstract][Full Text] [Related]
40. Advanced glycation end-product Nε-carboxymethyl-Lysine accelerates progression of atherosclerotic calcification in diabetes.
Wang Z; Jiang Y; Liu N; Ren L; Zhu Y; An Y; Chen D
Atherosclerosis; 2012 Apr; 221(2):387-96. PubMed ID: 22305260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]